Methods for administering aripiprazole
US8338427B2 · kind B2 · utility
29Cited by
6References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 15, 2008 |
| Grant date | Dec 25, 2012 |
| Priority date | — |
| Expiry date | May 25, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in part, to the discovery that a pharmaceutical composition comprising aripiprazole and a carrier administered in a bolus injection resulted in an extended release profile similar to that obtained by the injection of a poly lactide-co-glycolide microsphere formulation containing the active agent. This surprising result suggests that pharmacologically beneficial extended release formulations without the complexities and expense associated with the manufacture microspheres.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.